Artwork

Content provided by phaware global association and Phaware global association. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by phaware global association and Phaware global association or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Episode 292 - Richard Pietroski

8:39
 
Share
 

Manage episode 244775429 series 1547852
Content provided by phaware global association and Phaware global association. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by phaware global association and Phaware global association or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Richard Pietroski is President of Lung Bioengineering at United Therapeutics Corporation. Richard discusses the advancements his organization has made in ex-vivo lung perfusion (EVLP). His team’s revolutionary work has kept lungs outside the body for up to 22 hours, whereas in the past, lungs needed to be transplanted within six hours. Lung Bioengineering’s goal is to double the number of lungs transplanted annually in the U.S.

Learn more about pulmonary hypertension trials at www.phaware.global/clinicaltrials. Never miss an episode with the phaware® podcast app. Follow us @phaware on Facebook, Twitter, Instagram, YouTube & Linkedin Engage for a cure: www.phaware.global/donate #phaware #ClinicalTrials @antidote_me

  continue reading

470 episodes

Artwork
iconShare
 
Manage episode 244775429 series 1547852
Content provided by phaware global association and Phaware global association. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by phaware global association and Phaware global association or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Richard Pietroski is President of Lung Bioengineering at United Therapeutics Corporation. Richard discusses the advancements his organization has made in ex-vivo lung perfusion (EVLP). His team’s revolutionary work has kept lungs outside the body for up to 22 hours, whereas in the past, lungs needed to be transplanted within six hours. Lung Bioengineering’s goal is to double the number of lungs transplanted annually in the U.S.

Learn more about pulmonary hypertension trials at www.phaware.global/clinicaltrials. Never miss an episode with the phaware® podcast app. Follow us @phaware on Facebook, Twitter, Instagram, YouTube & Linkedin Engage for a cure: www.phaware.global/donate #phaware #ClinicalTrials @antidote_me

  continue reading

470 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide